164 related articles for article (PubMed ID: 1650931)
1. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.
Matthews PM; Francis G; Antel J; Arnold DL
Neurology; 1991 Aug; 41(8):1251-6. PubMed ID: 1650931
[TBL] [Abstract][Full Text] [Related]
2. High resolution proton NMR spectroscopy of multiple sclerosis lesions.
Davies SE; Newcombe J; Williams SR; McDonald WI; Clark JB
J Neurochem; 1995 Feb; 64(2):742-8. PubMed ID: 7830068
[TBL] [Abstract][Full Text] [Related]
3. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease.
Kimura H; Grossman RI; Lenkinski RE; Gonzalez-Scarano F
AJNR Am J Neuroradiol; 1996 Sep; 17(8):1539-47. PubMed ID: 8883654
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients.
Siger-Zajdel M; Selmaj K
Eur J Neurol; 2006 Mar; 13(3):296-8. PubMed ID: 16618349
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease.
Arnold DL; Matthews PM; Francis G; Antel J
Magn Reson Med; 1990 Apr; 14(1):154-9. PubMed ID: 2161982
[TBL] [Abstract][Full Text] [Related]
6. Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis--ringlike appearances in acute plaques.
Landtblom AM; Sjöqvist L; Söderfeldt B; Nyland H; Thuomas KA
Acta Radiol; 1996 May; 37(3 Pt 1):278-87. PubMed ID: 8845254
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo.
Bruhn H; Frahm J; Merboldt KD; Hänicke W; Hanefeld F; Christen HJ; Kruse B; Bauer HJ
Ann Neurol; 1992 Aug; 32(2):140-50. PubMed ID: 1324631
[TBL] [Abstract][Full Text] [Related]
8. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
9. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.
Sarchielli P; Presciutti O; Pelliccioli GP; Tarducci R; Gobbi G; Chiarini P; Alberti A; Vicinanza F; Gallai V
Brain; 1999 Mar; 122 ( Pt 3)():513-21. PubMed ID: 10094259
[TBL] [Abstract][Full Text] [Related]
10. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy.
Richards TL
AJR Am J Roentgenol; 1991 Nov; 157(5):1073-8. PubMed ID: 1927795
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy of brain in congenital myotonic dystrophy.
Hashimoto T; Tayama M; Yoshimoto T; Miyazaki M; Harada M; Miyoshi H; Tanouchi M; Kuroda Y
Pediatr Neurol; 1995 May; 12(4):335-40. PubMed ID: 7546006
[TBL] [Abstract][Full Text] [Related]
12. [Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis].
Watanabe H; Fukatsu H; Ito T; Iijima M; Mabuchi N; Sobue G
Nihon Rinsho; 2003 Aug; 61(8):1435-41. PubMed ID: 12962035
[TBL] [Abstract][Full Text] [Related]
13. [The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
Szafirska M; Urbanik A; Róg T
Przegl Lek; 2013; 70(5):328-34. PubMed ID: 23944105
[TBL] [Abstract][Full Text] [Related]
14. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
Simone IL; Federico F; Trojano M; Tortorella C; Liguori M; Giannini P; Picciola E; Natile G; Livrea P
J Neurol Sci; 1996 Dec; 144(1-2):182-90. PubMed ID: 8994122
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in the evaluation of children with congenital heart disease and acute central nervous system injury.
Ashwal S; Holshouser BA; Hinshaw DB; Schell RM; Bailey L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):403-14. PubMed ID: 8751509
[TBL] [Abstract][Full Text] [Related]
16. The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis.
Simone IL; Tortorella C; Federico F
Ital J Neurol Sci; 1999; 20(5 Suppl):S241-5. PubMed ID: 10662956
[TBL] [Abstract][Full Text] [Related]
17. A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases.
Confort-Gouny S; Vion-Dury J; Nicoli F; Dano P; Donnet A; Grazziani N; Gastaut JL; Grisoli F; Cozzone PJ
J Neurol Sci; 1993 Sep; 118(2):123-33. PubMed ID: 8229060
[TBL] [Abstract][Full Text] [Related]
18. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis.
Larsson HB; Christiansen P; Jensen M; Frederiksen J; Heltberg A; Olesen J; Henriksen O
Magn Reson Med; 1991 Nov; 22(1):23-31. PubMed ID: 1798392
[TBL] [Abstract][Full Text] [Related]
19. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis.
Tartaglia MC; Narayanan S; De Stefano N; Arnaoutelis R; Antel SB; Francis SJ; Santos AC; Lapierre Y; Arnold DL
J Neurol; 2002 Oct; 249(10):1382-90. PubMed ID: 12382153
[TBL] [Abstract][Full Text] [Related]
20. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
Arnold DL; Riess GT; Matthews PM; Francis GS; Collins DL; Wolfson C; Antel JP
Ann Neurol; 1994 Jul; 36(1):76-82. PubMed ID: 8024266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
